Joshua Salvin

Publications

1. Investigation of a Novel Noninvasive Risk Analytics Algorithm With Laboratory Central Venous Oxygen Saturation Measurements in Critically Ill Pediatric Patients. Crit Care Explor. 2025 Jan; 7(1):e1204. View Abstract
2. A Near Real-Time Risk Analytics Algorithm Predicts Elevated Lactate Levels in Pediatric Cardiac Critical Care Patients. Crit Care Explor. 2023 Dec; 5(12):e1013. View Abstract
3. Complex decision making in an intensive care environment: Perceived practice versus observed reality. J Eval Clin Pract. 2024 03; 30(2):337-345. View Abstract
4. Factors associated with morbidity, mortality, and hemodynamic failure after biventricular conversion in borderline hypoplastic left hearts. J Thorac Cardiovasc Surg. 2023 09; 166(3):933-942.e3. View Abstract
5. Associations With Extubation Failure and Predictive Value of Risk Analytics Algorithms With Extubation Readiness Tests Following Congenital Cardiac Surgery. Pediatr Crit Care Med. 2022 04 01; 23(4):e208-e218. View Abstract
6. Use of a Risk Analytic Algorithm to Inform Weaning From Vasoactive Medication in Patients Following Pediatric Cardiac Surgery. Crit Care Explor. 2021 Nov; 3(11):e0563. View Abstract
7. Fluid Restriction Contributes to Poor Nutritional Adequacy in Patients With Congenital Heart Disease Receiving Renal Replacement Therapy. J Ren Nutr. 2022 01; 32(1):78-86. View Abstract
8. Shock Index, Coronary Perfusion Pressure, and Rate Pressure Product As Predictors of Adverse Outcome After Pediatric Cardiac Surgery. Pediatr Crit Care Med. 2021 01 01; 22(1):e67-e78. View Abstract
9. Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy. Pediatr Crit Care Med. 2019 11; 20(11):1069-1077. View Abstract
10. Acute coronary artery obstruction following surgical repair of congenital heart disease. J Thorac Cardiovasc Surg. 2020 05; 159(5):1957-1965.e1. View Abstract
11. Inadequate oxygen delivery index dose is associated with cardiac arrest risk in neonates following cardiopulmonary bypass surgery. Resuscitation. 2019 09; 142:74-80. View Abstract
12. Renal replacement therapy in the pediatric cardiac intensive care unit. J Thorac Cardiovasc Surg. 2019 11; 158(5):1446-1455. View Abstract
13. RBC Exposure in Pediatric Extracorporeal Membrane Oxygenation: Epidemiology and Factors Associated With Large Blood Transfusion Volume. Pediatr Crit Care Med. 2018 08; 19(8):767-774. View Abstract
14. Responsive monitoring of mitochondrial redox states in heart muscle predicts impending cardiac arrest. Sci Transl Med. 2017 Sep 20; 9(408). View Abstract
15. Pediatric Cardiac Intensive Care Society 10th International Conference 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care. Pediatr Crit Care Med. 2016 Mar; 17(3 Suppl 1):S1-2. View Abstract
16. Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Antiarrhythmics. Pediatr Crit Care Med. 2016 Mar; 17(3 Suppl 1):S49-58. View Abstract
17. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery: a randomized, double-blind, placebo-controlled trial. Circ Heart Fail. 2014 Jul; 7(4):596-604. View Abstract
18. The association of carotid artery cannulation and neurologic injury in pediatric patients supported with venoarterial extracorporeal membrane oxygenation*. Pediatr Crit Care Med. 2014 May; 15(4):355-61. View Abstract
19. Extracorporeal membrane oxygenation in patients undergoing superior cavopulmonary anastomosis. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1512-8. View Abstract
20. Great need, scarce resources, and choice: reflections on ethical issues following a medical mission. J Clin Ethics. 2014; 25(4):311-3. View Abstract
21. Outcomes of transcatheter approach for initial treatment of pulmonary atresia with intact ventricular septum. Catheter Cardiovasc Interv. 2013 Jan 01; 81(1):111-8. View Abstract
22. Quality of life of pediatric cardiac patients who previously required extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2012 Jul; 13(4):428-34. View Abstract
23. Extracorporeal membrane oxygenation after stage 1 palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1337-43. View Abstract
24. Acute kidney injury and critical cardiac disease. World J Pediatr Congenit Heart Surg. 2011 Jul 01; 2(3):411-23. View Abstract
25. Perioperative factors associated with prolonged mechanical ventilation after complex congenital heart surgery. Pediatr Crit Care Med. 2011 May; 12(3):e122-6. View Abstract
26. Risk factors for failed staged palliation after bidirectional Glenn in infants who have undergone stage one palliation. Eur J Cardiothorac Surg. 2011 Oct; 40(4):1000-6. View Abstract
27. Extracorporeal membrane oxygenation support after the Fontan operation. J Thorac Cardiovasc Surg. 2011 Sep; 142(3):504-10. View Abstract
28. Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay. Ann Thorac Surg. 2011 Jan; 91(1):204-10. View Abstract
29. Right ventricle and tricuspid valve function at midterm after the Fontan operation for hypoplastic left heart syndrome: impact of shunt type. Pediatr Cardiol. 2011 Feb; 32(2):160-6. View Abstract
30. Neurological injury after extracorporeal membrane oxygenation use to aid pediatric cardiopulmonary resuscitation. Pediatr Crit Care Med. 2009 Jul; 10(4):445-51. View Abstract
31. Right ventricle and tricuspid valve function at mid-term following the Fontan operation for Hypoplastic Left Heart Syndrome: Impact of shunt type. 2009. View Abstract
32. Transfusion Following Pediatric Cardiac Surgery is Associated with Prolonged Hospital Stay. 2009; In review. View Abstract
33. Myocarditis and Pericarditis. Pediatric Infectious Diseases, Samir Shah, editor. 2008; in press. View Abstract
34. Red Blood Transfusion in Post-Cardiac Surgical Patients is Associated with Prolonged Hospital Stay. 2008. View Abstract
35. Extracorporeal membrane oxygenation for postcardiotomy mechanical cardiovascular support in children with congenital heart disease. Paediatr Anaesth. 2008 Dec; 18(12):1157-62. View Abstract
36. Factors associated with prolonged recovery after the fontan operation. Circulation. 2008 Sep 30; 118(14 Suppl):S171-6. View Abstract
37. Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit. J Am Coll Cardiol. 2008 Jul 01; 52(1):52-9. View Abstract
38. Factors Associated with Prolonged Recovery Following the Fontan Operation. Circulation Surgical Supplement. 2008; in press. View Abstract
39. Survival and Clinical Course at Stage One Palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit. Journal of the American College of Cardiology. 2008; in press. View Abstract
40. MSICU Surgical Handbook. 2007. View Abstract
41. Predictors of Non-Favorable CICU Outcome Following the Fontan Operation. Circulation. 2007; 116(II):479. View Abstract
42. Fetal tricuspid valve size and growth as predictors of outcome in pulmonary atresia with intact ventricular septum. Pediatrics. 2006 Aug; 118(2):e415-20. View Abstract
43. Improving outcomes in fetuses and neonates with congenital displacement (Ebstein's malformation) or dysplasia of the tricuspid valve. Am J Cardiol. 2005 Aug 15; 96(4):582-6. View Abstract
44. ECMO following cardiac surgery from the KID 2000 database. Pediatric Critical Care Medicine. 2005; 6(3):398. View Abstract
45. Volume Expansion in the Post-Operative Fontan Patient Predicts Extended Duration of Mechanical Ventilation and CICU Length of Stay. Pediatric Critical Care Medicine. 2005. View Abstract
46. Morbidity and Mortality Following ECMO for Cardiac Surgery from the KID 1997 and 2000 Databases. Circulation. 2005; 112(II):518. View Abstract
47. Fetal tricuspid valve annulus as a predictor of single vs. biventricular outcome in pulmonary atresia with intact ventricular septum: implications for fetal intervention. Circulation. 2003; 108(IV):609. View Abstract
48. Outcome of severe Ebstein’s anomaly and tricuspid valve dysplasia in the fetus and neonate. Circulation. 2003; 108(IV):609. View Abstract
49. Senior Rounds Case Reports 2001-2002. 2002. View Abstract
50. The Children's Hospital of Philadelphia Pediatric Intern Survival Guide. 2000. View Abstract
51. Does parental origin of 22q11 deletion influence the phenotypic outcome in DiGeorge and velocardiofacial syndromes?. American College of Medical Genetics. 1995. View Abstract
52. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet. 1993 Oct; 30(10):813-7. View Abstract
Show All Publications Show Fewer Publications